CompuGroup Medical SE & Co. KGaA’s Post

Exploring New Frontiers in Pharmacy software Exciting developments at ARZ Haan AG as we announce our collaboration with Equasens in acquiring ADV, soon to be rebranded as Pharmagest Germany. David Oruzgani and I are really looking forward to working with Denis SUPPLISSON and his team. This partnership signifies a strategic move to strengthen our position in the German pharmacy market. Our combined expertise aims to deliver enhanced, user-friendly software solutions for pharmacies, building on decades of industry experience. This effort is particularly focused on empowering local pharmacies, ensuring they have the tools and resources to excel in a rapidly evolving healthcare landscape. Our ambition is to be among the top pharmacy software providers in Germany within the next five years. This joint venture with Equasens will enable us to develop advanced software solutions tailored to the evolving needs of pharmacies. I'd also like to extend a special congratulations to Rupert Sierp and the team of ADV, soon Pharmagest Germany. Their expertise will be pivotal in achieving our goals and supporting local pharmacies. We are committed to innovating and providing efficient solutions for the pharmacy sector, ensuring that pharmacies are well-equipped for the future. #PharmacySoftware #HealthcareInnovation #StrategicPartnership #LocalPharmacySupport #futureofhealthcare #betterARZ ARZ Service arz.digital GmbH Pharmagest Interactive Pharmagest Italia

AlFajr Pharmacy distinguishes itself as a hub for fostering innovation and creativity within the realm of healthcare. At the core of our ethos lies a commitment to pushing boundaries and exploring new avenues to enhance patient care. One way we stimulate innovation is by cultivating a culture of continuous learning and professional development among our staff. Through regular training sessions, workshops, and opportunities for skill enhancement, we empower our team to stay abreast of the latest advancements in pharmaceutical science and patient care practices. Moreover, AlFajr Pharmacy actively encourages an environment where ideas are welcomed and collaboration is championed. We believe that innovation thrives in an atmosphere of open dialogue and shared insights. Our staff members are encouraged to voice their ideas, whether they pertain to improving operational efficiency, enhancing customer service, or introducing novel healthcare solutions. By fostering a culture of inclusivity and respect, we create a fertile ground for creativity to flourish, leading to innovative approaches that benefit both our customers and our organization as a whole. Furthermore, AlFajr Pharmacy leverages technology as a catalyst for innovation, constantly seeking out new tools and platforms to streamline processes and enhance the patient experience. From implementing state-of-the-art dispensing systems to offering telepharmacy services for remote consultations, we harness the power of innovation to make healthcare more accessible, efficient, and tailored to individual needs. By embracing technology as an enabler of progress, we position ourselves at the forefront of innovation in the pharmacy sector, ensuring that our customers receive the highest standard of care in an ever-evolving healthcare landscape. #AlFajr #pharmacy #care #healthcare #cure #sheikhupura #lifecorner

Let's Hear it for Bill Richards, VP Market Access at argenx! Bill Richards, the visionary Market Access leader behind the product launch of Vyvgart at argenx, deserves a round of applause for his incredible work. He had a crystal-clear vision of what he wanted to achieve and handpicked a remarkable market access team to bring that vision to life. argenx has an ambitious plan to launch 5 products in 5 years, and Bill's strategic thinking revolved around building a team that would ensure sustainable growth. But what sets Bill and the entire team at argenx apart is their unwavering focus on the patient. They prioritize the patient's well-being above all else, consistently asking, "How will this impact the patient?" Understanding the importance of access to their life-changing products, Bill knew that innovation was necessary. He took a unique approach to partner with distributors in order to get product to the patients is a more effective way. Let's give a resounding cheer for Bill Richards and the entire team at argenx for their dedication to improving patient outcomes and revolutionizing the way products reach those in need. Together, they are making a positive impact and paving the way for a healthier future. Read more here: https://bit.ly/3XuQzLo #LetsHearIt #TwoLabsTurns20

And so to our next chapter….. Exciting times ahead, more collaborations, more options and solutions to offer all of our #orthopaedic #surgeons and #patients looking forward to rising to the new challenges! 🦾 #customerfocussed #puttingpatientsfirst #strongertogether #creatingbettertogether

Today I’d like to take the opportunity to spotlight one of DB Group Investments' and North First Ventures - N1V’s portfolio company BioT Medical. As a visionary entity within the DB Group, BioT Medical has been a trailblazer in the MedTech sector since its inception in 2018. What truly sets BioT Medical apart is its groundbreaking cloud-based platform. This innovation enables seamless and instantaneous connections among caregivers, patients, pharmaceutical companies, and medical device firms. In today's rapidly evolving healthcare landscape, the importance of data security and operational reliability cannot be overstated. BioT Medical’s recent achievement of SOC 2 Type II certification is a testament to their unwavering commitment to these principles. I think BioT Medical's work exemplifies the transformative potential of collaboration across borders. Their technology is not just a tool for improving healthcare; it's a bridge that connects diverse stakeholders, fostering a more integrated and effective global healthcare ecosystem. The dedication and passion of BioT Medical’s team are truly inspiring. They share a unified vision of making world-class medical care accessible to all, and their innovative spirit is what makes this company exceptional. As we look to the future, it's clear that companies like BioT Medical will play a pivotal role in shaping the healthcare landscape. For those in the MedTech and investment communities, what challenges and opportunities do you anticipate in ensuring data security and operational reliability? Check out BioT Medical’s vision here > https://lnkd.in/egpi6bzt #MedTech #Healthcare #ConnectedCare

From copay and financial services to product integrity, Accredo goes beyond the role of a typical specialty pharmacy to support manufacturers to help ensure optimal patient access. Read the latest Insights article for more on our unique service model. #WeAreTheCignaGroup #specialtypharmacy

Embarking on Operational Excellence at Ypsomed 🚀 In my role at Ypsomed, my focus is set squarely on achieving operational excellence in the global industrialisation of our Diabetes Care Line. For me, this translates to a strategic effort to enhance our time to market. Although I'm still in the early stages of my journey with Ypsomed, I'm already contemplating key considerations for driving operational efficiency: 1. Direct Impact Focus: Industrialisation involves a web of internal and external stakeholders. To navigate this complexity effectively, prioritise your attention on areas where your influence is direct. Leave processes further down the line for later consideration. 2. Balancing Efficacy and Quality: In the pursuit of efficiency, never compromise on quality. Our products profoundly impact millions of lives, and stringent processes are in place to ensure their safe creation and usage. While these processes may extend our time to market, they serve as critical safeguards against the risks associated with malfunctioning products, benefiting both patients and the company. 3. Start Small, Scale Wisely: The temptation to make a sweeping impact or implement proven methods on a large scale is common. However, recognising the unique dynamics of each company, it's wiser to initiate trial methodologies in a small group, with those closest to you and your projects. If successful, you can then progressively broaden the scope to a larger audience. Here's to the journey of continuous improvement! 🌐💪 #OperationalExcellence #HealthcareInnovation #YpsomedJourney

Come and meet us to discuss your next clinical trial

❓ Did you know that DTA and ClearView Healthcare Partners published the DTx Commercial Launch Playbook? 💡 The playbook is designed to provide a standard set of launch considerations to help execute a successful product launch and understand the resources necessary to launch and scale 📣 Freespira has done a case study on their use of the launch playbook: https://lnkd.in/eNXiTSSs 📢 DTA and Clearview are hosting monthly Commercialization Meet-Ups, workshops for a deeper dive on the different tabs of the launch playbook. The next meet-up will be LIVE at the DTA Summit! https://lnkd.in/eGUNQykk 🌍 The launch playbook has been translated into Korean 👩💻 The launch playbook was developed in the DTA Commercialization Task Group To learn more about DTA Task Groups, member resources, and initiatives contact: Hazel@dtxalliance.org Lani Hessen, OTR/L Jonathan Hodgson Graeme Steller Austin Hubbert #DTA #DTx #Digitaltherapeutics #Medtech #digitalHealth

A smooth #sales process and fast distribution of medical supplies for our customers is indispensable and imperative. However, it’s our core values that holds the company together and keeps our customers at DubiMed coming back. Here are 5 of the core values we practice: ✰ Respect ✰ Trust ✰ Loyalty ✰ Transparency ✰ Honesty The product we deliver can be simple, expensive, or complex, but one factor still remains at DubiMed #Trust is placed in our hands every day to deliver high-quality products patients can use safely to feel better and achieve their goals. It’s the backbone of our business and what makes our customers feel successful. #DubiMed #SafiRajab #leadership #growth #innovation #trust #aesthetics #CEO